Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
586 News Items found
Christina Leslie
Decoding the Cell: A Conversation with Dr. Christina Leslie

Dr. Christina Leslie’s work sits at the crossroads of two technological revolutions: single-cell genomics and artificial intelligence. We sat down with Dr. Leslie to discuss the promise — and limitations — of this technological frontier, and what it means for cancer research.
Detail of a researcher working in an MSK lab
MSK Research Highlights, October 22, 2026

New MSK research shows how genes activate across vast distances inside a cell; identifies a new form of cell death that could open new opportunities for cancer therapy; uncovers hidden genetics involved in autism; develops an AI tool that can predict a cell’s fate and help change it; and finds STAT3 acts as an inflammation-sensing switch in natural killer cells.
an MSK researcher looks through a microscope
MSK Research Highlights, October 9, 2026

New MSK research uncovers an unknown role for immune cells in fueling triple-negative breast cancer; identifies a new strategy for fighting leptomeningeal metastases; finds trastuzumab deruxtecan shows enhanced benefit for patients with ERBB2 mutations in breast cancer; shows tumor DNA insights can help guide treatment for patients with hard-to-treat biliary tract cancers; and uses artificial intelligence (AI) to study early development.
Zaza Gelashvili, Miklos Lengyel, Philipp Niethammer, Yanan Ma
Of Mice and Zebrafish: How MSK Scientists Solved a Decades-Old Mystery and Uncovered New Insights About Inflammation

A team of MSK researchers solved a decades-old scientific puzzle and revealed that a critical inflammatory signaling pathway doesn’t just summon immune cells to the place where they’re needed — it also protects healthy cells from being damaged by the immune response.
scientific image of lung cancer
Using Nanoparticles To Target Fibrosis in Cancer and Other Diseases

Scientists at MSK have developed a new nanoparticle-based approach to breaking down fibrosis in cancer and other diseases, which could make immunotherapy more effective. Learn about their findings in laboratory models.
Agnel Sfeir
Scientists Uncover an Achilles’ Heel in Cancer’s ‘Rogue DNA’

MSK researchers have discovered that a type of rogue DNA found in aggressive cancers has a hidden structural weakness — and that blocking a single repair protein can cause it to fall apart, suggesting a new therapeutic opportunity.
GSK student Zaza Gelashvili
2026 GSK Chairman’s Prize Recognizes Research on How Cells Sense Injury

This year's GSK Chairman’s Prize was awarded to Zaza Gelashvili for his research on how cells sense injury.
MSK logo visible on sleeve of lab coat
Fueling the Next Generation of Biomedical Research

Sixteen exceptional early-career scientists are advancing groundbreaking biomedical research at MSK thanks to the generous support of MSK philanthropists. These postdoctoral researchers, selected for their innovative research proposals and scientific promise, represent the future of oncology discovery. 
An MSK researcher reviews images on a screen
MSK Research Highlights, September 14, 2026

New MSK research shows how a metabolite boosts immune cells against cancer; adds to the understanding of how colorectal cancer spreads; reveals tumor CD19 levels may predict the success of CAR T cell therapy; and finds a new targeted drug combination shows promise in early trial for small cell lung cancer.
Caleb Lareau
Using AI To Design Better Cancer Therapies

How MSK researchers are using artificial intelligence (AI) to design better "binders" for CAR T cell therapies.